Android app Apple app link

Okyo Pharma receives $1.4M in non-dilutive financing

By Yahoo! Finance   |   1 day ago
Okyo Pharma receives $1.4M in non-dilutive financing

OKYO Pharma secures $1.4M non-dilutive funding to advance its pipeline, particularly focusing on lead program OK-101 for NCP treatment, preserving shareholder value and supporting R&D efforts.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.